Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Fate Therapeutics, Inc. (NASDAQ:FATE) Receives Average Recommendation of "Hold" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Fate Therapeutics (NASDAQ:FATE) Price Target Raised to $6.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) shares shot up 5.1% on Monday . The stock traded as high as $7.01 and last traded at $6.95. 1,069,935 shares traded hands during trading, a decline of 64% from the average session volume of 2,953,319 shares. The stock had previously closed at $6.61. Analysts Set New […]
Wedbush Increases Fate Therapeutics (NASDAQ:FATE) Price Target to $7.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.